In our study, we have shown that only the CD44hi/CD24lo and ALDH1 combination significantly correlates with DFS and OS, especially in neoadjuvant chemotherapy-receiving breast cancer patients, and this was observed in both TNBC and non-TNBC subtypes. This evidence concerns the gene ALDH1A1 and breast carcinoma.